← Back to all trials
Completed
NCT07837856
Therapeutic Adherence in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2/Prevention & Control, Diabete Type 2, Treatment Adherence
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 250
Sponsor: Instituto Mexicano del Seguro Social
Location: Family Medicine Unit No. 84 Morelia Michoacán
Summary
A quasi-experimental, non-randomized, prospective, longitudinal study comparing the use of WhatsApp messaging versus the SMART technique in patients with type 2 diabetes to improve treatment adherence
Eligibility Criteria
Inclusion Criteria:
* • Patients with type 2 diabetes mellitus.
* Patients enrolled in UMF 84.
* Men and women between the ages of 35 and 70.
* Patients who agree to participate, understand the informed consent form, and sign it.
* Patients who have a cell phone and the WhatsApp app.
Exclusion Criteria:
* • Patients with type 1 diabetes mellitus.
* Patients with dementia, schizophrenia, alcoholism, drug addiction, cancer, Parkinson's disease, hearing and vision impairments, and comprehension and language disorders.
* Pregnant patients.
* Patients who cannot read or write.
Exclusion Criteria
* Patients who withdraw their consent.
* Patients who fail to attend laboratory tests, questionnaire administration, or regular medical appointments.
* Patient death.
* Changes in health insurance enrollment.
* Loss of health insurance coverage.
Source: ClinicalTrials.gov (NCT07837856). StuddyBuddy aggregates publicly available trial information.
